1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Drug News 25 MAY 2015

Cancer Drug News 25 MAY 2015

  • May 2015
  • -
  • Espicom Business Intelligence
  • -
  • 12 pages

Industry Trend Analysis - Speedy Approvals Increasing Fast Track Designation Appeal
Industry Brief - GlycoMimetics Initiates Phase I/IIl Trial of GMI-1271 In AML
Industry Brief - Opdivo Gains CHMP Positive Opinion For Previously-Treated Advanced Squamous NSCLC
Industry Brief - CVac Phase II Study Shows OS Benefit Over SoC In Second Remission OC
Industry Brief - PsiOxus Raises Funds For Oncolytic Virus/Checkpoint Inhibitor Combination Study
Industry Brief - DSMB Recommends Increasing Patient Sample Size In Xilonix Phase III CRC Study
Industry Trend Analysis - OctreoPharm Acquisition Will Strengthen Ipsen's NET Presence
Industry Brief - Novartis' Afinitor Phase III Study Extends PFS In Advanced GI Or Lung NET
Industry Brief - DNAtrix To Use Alcyone's AMC Delivery Platform For DNX-2401 In Glioblastoma
Industry Brief - Eisai Launches Lenvima In Japan For Unresectable TC
Industry Brief - BioNTech/Genmab Collaborate To Develop Bispecific Abs In Immuno-Oncology
Industry Trend Analysis - Biologics Will Front AstraZeneca's Oncology Reinvigoration
Industry Brief - Sorrento Establishes Subsidiary With Cellular Immunotherapy Focus
Industry Trend Analysis - Local Oncology Presence Continues To Grow
Industry Brief - Cancer Conferences - August 2015

Table Of Contents

Cancer Drug News 25 MAY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Hematological Cancers: Analytical Tool

Hematological Cancers: Analytical Tool

  • $ 10 125
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Drugs and Diagnostics for Hematological Disorders: Global Markets

Drugs and Diagnostics for Hematological Disorders: Global Markets

  • $ 6 650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Receive detailed information regarding screening, testing and treatment options for hematological disorders and blood cancer. - Learn about the types of diagnostic and treatment ...


Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.